Hill-Rom Holdings Inc (NYSE:HRC) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Sunday.

Other equities research analysts have also recently issued reports about the company. Barclays PLC lifted their target price on Hill-Rom Holdings from $75.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, May 1st. Zacks Investment Research cut Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Thursday, May 25th. Cantor Fitzgerald began coverage on Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “neutral” rating and a $86.00 target price for the company. Needham & Company LLC initiated coverage on Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “buy” rating and a $95.00 target price for the company. Finally, Stifel Nicolaus raised their price target on Hill-Rom Holdings from $70.00 to $84.00 and gave the stock a “buy” rating in a research report on Monday, May 1st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $88.17.

Shares of Hill-Rom Holdings (NYSE HRC) opened at 75.32 on Friday. The stock’s 50 day moving average price is $80.60 and its 200 day moving average price is $72.15. The stock has a market capitalization of $4.96 billion, a P/E ratio of 43.89 and a beta of 1.22. Hill-Rom Holdings has a one year low of $50.50 and a one year high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last released its earnings results on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.01. The company had revenue of $689.10 million during the quarter, compared to analysts’ expectations of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period last year, the firm earned $0.81 EPS. On average, analysts forecast that Hill-Rom Holdings will post $3.83 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This article was first posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.americanbankingnews.com/2017/08/06/hill-rom-holdings-inc-nysehrc-rating-increased-to-hold-at-bidaskclub.html.

In other news, SVP Andreas G. Frank sold 10,660 shares of the firm’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total value of $838,089.20. Following the transaction, the senior vice president now directly owns 28,988 shares in the company, valued at approximately $2,279,036.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Paul Sherwood Johnson sold 2,078 shares of the firm’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total value of $150,239.40. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Independent Portfolio Consultants Inc. boosted its stake in shares of Hill-Rom Holdings by 171.5% in the second quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after buying an additional 849 shares during the period. Meadow Creek Investment Management LLC boosted its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock valued at $120,000 after buying an additional 64 shares during the period. Neuburgh Advisers LLC boosted its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock valued at $165,000 after buying an additional 88 shares during the period. Tyers Asset Management LLC boosted its stake in shares of Hill-Rom Holdings by 3.9% in the first quarter. Tyers Asset Management LLC now owns 2,968 shares of the medical technology company’s stock valued at $210,000 after buying an additional 112 shares during the period. Finally, Bancorpsouth Inc. purchased a new stake in shares of Hill-Rom Holdings during the first quarter valued at $210,000. Institutional investors and hedge funds own 83.94% of the company’s stock.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Analyst Recommendations for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.